IGFBP5 boosts periodontal bone repair by reviving aging stem cells

Researchers at Sichuan University found that restoring IGFBP5 reduced senescence in dental follicle stem cells and improved periodontal bone regeneration in rats. The work points to a possible stem cell rejuvenation strategy for age-related tooth-supporting bone loss.

Why it matters: - Periodontitis can progressively destroy the bone and tissue that support teeth. - Aging weakens dental stem cells, limiting the body’s ability to repair periodontal damage. - The study suggests IGFBP5 could become a target for rejuvenating therapeutic stem cells before transplantation. - The findings may also inform broader regenerative medicine efforts where stem cell aging is a barrier.

What happened: - A research team led by Professor Jun Liu at Sichuan University studied how IGFBP5 affects dental follicle stem cells and periodontal repair. - The team published the findings online in International Journal of Oral Science on Sept. 15, 2026. - The original paper is titled “IGFBP5 alleviates periodontitis by reversing human dental follicle stem cell senescence via the non-canonical Wnt pathway.” - The DOI is 10.1038/s41368-026-00463-2. - The work combined cell experiments, gene-expression profiling, protein analysis, a biomaterial delivery system and a rat model of periodontitis.

The details: - Dental follicle stem cells are promising for periodontal regeneration, but they can become senescent and lose bone-forming ability. - IGFBP5 expression dropped sharply in senescent human dental follicle stem cells. - Under oxidative stress, IGFBP5 fell by more than fivefold. - During replicative senescence, IGFBP5 fell by 69-fold. - Senescent cells showed more oxidative stress, lower viability, weaker migration and reduced osteogenic activity. - Restoring IGFBP5 reduced senescence-associated changes, lowered reactive oxygen species and improved cell-cycle activity. - IGFBP5 also restored bone-formation markers in stressed stem cells. - Gene-expression analysis pointed to the non-canonical Wnt pathway as part of the mechanism. - IGFBP5 overexpression reduced WNT5B and c-Jun. - Components of the canonical Wnt/β-catenin pathway stayed largely unchanged. - Adding WNT5B weakened IGFBP5’s bone-forming effects and increased a senescence marker. - Blocking WNT5B partially improved senescent and osteogenic features in replicatively senescent cells. - The results suggest IGFBP5 supports aging dental follicle stem cells partly by suppressing WNT5B-related signaling. - The team built a delivery scaffold called Gel-vHA@oe-DFSC. - The scaffold combined a gelatin methacryloyl hydrogel, vinyl-functionalized nanohydroxyapatite and DFSCs engineered to overexpress IGFBP5. - In lab tests, the hydrogel supported cell survival under oxidative stress, improved cell spreading and boosted osteogenic activity. - In rats with induced periodontitis, the treatment improved alveolar bone quality, increased bone mineral density and raised bone volume fraction. - The treated tissue also showed less inflammation and better collagen organization.

Between the lines: - The study shifts the focus from simply transplanting stem cells to repairing the cells first. - That approach could matter because aged or stressed cells may underperform even when delivered successfully. - The work also positions IGFBP5 as a possible marker of dental follicle stem cell aging. - The hydrogel platform suggests localized delivery may help modified cells stay active at the defect site. - The study is still preclinical, so the results do not yet translate to patient care.

What’s next: - The authors say more studies are needed in cells from older patients. - Larger animal studies are also needed before clinical application. - Further work could test whether IGFBP5-based strategies translate to human periodontal regeneration. - The team’s next step may also include deeper study of the IGFBP5-WNT5B pathway in aged cells.

The bottom line: - IGFBP5 helped reverse stem cell aging signals and improved periodontal bone repair in a rat model, offering a plausible route to future regenerative treatments for age-related tooth-supporting bone loss.